How Should You Manage Rosacea?
Identify and avoid your personal triggers, establish a gentle skincare routine with mineral sunscreen, use prescribed topical treatments consistently, and consider laser therapy for persistent redness and visible blood vessels. A dermatologist can create a personalized treatment plan based on your rosacea subtype.
Start with trigger identification using a diary. The National Rosacea Society's most commonly reported triggers are sun exposure (81%), emotional stress (79%), hot weather (75%), wind (57%), heavy exercise (56%), alcohol (52%), hot baths (51%), cold weather (46%), spicy foods (45%), and humidity (44%). Once identified, avoidance of top triggers significantly reduces flare frequency.
A rosacea-friendly skincare routine includes a gentle, fragrance-free cleanser, moisturizer with ceramides and/or niacinamide, and mineral sunscreen (zinc oxide or titanium dioxide) SPF 30+. Chemical sunscreens can irritate rosacea-prone skin. Apply all products gently without rubbing. Green-tinted color-correcting primers can help camouflage redness. Introduce new products one at a time with a 2-week trial period.
NRS survey identified sun exposure (81%) and stress (79%) as top rosacea triggers
What Prescription Treatments Are Available?
Topical treatments include metronidazole (anti-inflammatory), azelaic acid (anti-inflammatory and antimicrobial), ivermectin (targets Demodex mites), and brimonidine gel (alpha-agonist vasoconstrictor for redness). Oral treatments include low-dose doxycycline (anti-inflammatory dose) for moderate-severe papulopustular rosacea. Laser therapy treats vascular components.
For papulopustular rosacea, topical ivermectin 1% cream (Soolantra) has emerged as a highly effective first-line option, showing superior efficacy to topical metronidazole in head-to-head trials. Applied once daily, it targets both inflammatory papules and the Demodex folliculorum mite implicated in rosacea pathogenesis. Azelaic acid 15% gel (Finacea) is another effective option with additional benefits for post-inflammatory pigmentation.
For persistent background erythema, brimonidine 0.33% gel (Mirvaso) and oxymetazoline 1% cream (Rhofade) provide temporary vasoconstriction reducing visible redness for 8-12 hours. These are used as-needed for social situations or daily maintenance. Pulsed dye laser (PDL) and intense pulsed light (IPL) treatments provide more lasting reduction of telangiectasia and background redness, typically requiring 2-4 sessions with maintenance treatments every 6-12 months.
Topical ivermectin showed superior efficacy to metronidazole in head-to-head trials

